Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of specialized blood vessels via lymphatic transdifferentiation. | Nature | 2022 | 35614218 | PubTator, text mining | PubMed |
| SOX17-mediated MALAT1-miR-199a-HIF1α axis confers sensitivity in esophageal squamous cell carcinoma cells to radiotherapy. | Cell Death Discov | 2022 | 35614065 | PubTator, text mining | PubMed |
| Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2022 | 35610614 | PubTator, text mining | PubMed |
| Remdesivir impairs mouse preimplantation embryo development at therapeutic concentrations. | Reprod Toxicol | 2022 | 35605700 | PubTator, text mining | PubMed |
| Chromatin remodeling is restricted by transient GATA6 binding during iPSC differentiation to definitive endoderm. | iScience | 2022 | 35602939 | PubTator, text mining | PubMed |
| CDX2-induced intestinal metaplasia in human gastric organoids derived from induced pluripotent stem cells. | iScience | 2022 | 35602937 | PubTator, text mining | PubMed |
| Polycomb Repressive Complexes: Shaping Pancreatic Beta-Cell Destiny in Development and Metabolic Disease. | Front Cell Dev Biol | 2022 | 35602600 | PubTator, text mining | PubMed |
| Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. | Biomed Res Int | 2022 | 35601155 | PubTator, text mining | PubMed |
| FGFR3 is expressed by human primordial germ cells and is repressed after meiotic initiation to form primordial oocytes. | Stem Cell Reports | 2022 | 35594860 | PubTator, text mining | PubMed |
| Esrrb is a cell-cycle-dependent associated factor balancing pluripotency and XEN differentiation. | Stem Cell Reports | 2022 | 35594859 | PubTator, text mining | PubMed |
| Micro-RNA-124-5p promotes insulin producing cell differentiation through regulating transcriptional factor NKX6.1. | Biochem Biophys Rep | 2022 | 35592615 | PubTator, text mining | PubMed |
| Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste? | Clin Transl Gastroenterol | 2022 | 35584320 | PubTator, text mining | PubMed |
| Lateral Mesoderm-Derived Mesenchymal Stem Cells With Robust Osteochondrogenic Potential and Hematopoiesis-Supporting Ability. | Front Mol Biosci | 2022 | 35573747 | PubTator, text mining | PubMed |
| Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck. | Front Med (Lausanne) | 2022 | 35572996 | PubTator, text mining | PubMed |
| Engineering Islets From Stem Cells: The Optimal Solution for the Treatment of Diabetes? | Front Immunol | 2022 | 35572568 | PubTator, text mining | PubMed |
| Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells. | Biomaterials | 2022 | 35567999 | PubTator, text mining | PubMed |
| PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration. | Thorac Cancer | 2022 | 35567329 | PubTator, text mining | PubMed |
| Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review. | Cancers (Basel) | 2022 | 35565347 | PubTator, text mining | PubMed |
| Current and Developing Liquid Biopsy Techniques for Breast Cancer. | Cancers (Basel) | 2022 | 35565189 | PubTator, text mining | PubMed |
| Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction. | Cells | 2022 | 35563692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=53